PDT Partners’s NEOPHOTONICS CORP NPTN Stock Holding History

PDT Partners’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,469	Closed	-$219K	–	968
2021 Q2	$219K	Buy	+21,469	New	+$227K	0.01%	685
2020 Q3	–	Sell	-153,160	Closed	-$1.36M	–	900
2020 Q2	$1.36M	Buy	153,160 +57,629	+60%	+$497K	0.09%	244
2020 Q1	$693K	Buy	95,531 +18,318	+24%	+$136K	0.05%	298
2019 Q4	$681K	Buy	77,213 +52	+0.1%	+$389	0.04%	357
2019 Q3	$470K	Sell	77,161 -53,739	-41%	-$302K	0.03%	344
2019 Q2	$547K	Buy	130,900 +63,100	+93%	+$333K	0.03%	301
2019 Q1	$426K	Buy	67,800 +1,811	+3%	+$12.7K	0.02%	327
2018 Q4	$428K	Buy	+65,989	New	+$505K	0.02%	339
2015 Q3	–	Sell	-58,590	Closed	-$535K	–	1665
2015 Q2	$535K	Buy	58,590 +37,273	+175%	+$283K	0.01%	954
2015 Q1	$144K	Buy	+21,317	New	+$85.7K	﹤0.01%	1309

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's NPTN Position: Q3 2021 in Review

PDT Partners sold out of NEOPHOTONICS CORP (NPTN) in Q3 2021, closing a stake of 21,469 shares — an estimated $219K sold.

PDT Partners first reported a position in NPTN in Q1 2015 and held it in 10 quarters. The position peaked at $1.36M in Q2 2020. 124 funds tracked by Wall St. Rank hold NPTN as of Q3 2021.

PDT Partners reported no remaining NEOPHOTONICS CORP position as of Q3 2021 after selling out during the quarter.
PDT Partners sold 21,469 NEOPHOTONICS CORP shares in Q3 2021, an estimated $219K.
PDT Partners first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 10 quarters.
PDT Partners's NEOPHOTONICS CORP position peaked at $1.36M in Q2 2020.
124 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.